The listed products belong to the category of transplant medicines, which are primarily used to prevent organ rejection after procedures such as kidney, liver, or heart transplantation. Medicines like Cellcept, Seromune, Mofecon, and Mofecon S generally contain Mycophenolate-based compounds, while Arpimune O contains Cyclosporine, both of which are immunosuppressive agents. These drugs work by suppressing the body’s immune system to prevent it from attacking the newly transplanted organ, thereby ensuring its proper acceptance and long-term function. Transplant medicines are a critical part of post-transplant care and are usually prescribed as lifelong therapy in combination with other immunosuppressants. They require strict medical supervision, regular monitoring, and precise dosage management to balance the prevention of organ rejection with the risk of infections and other side effects.